Midas Multispeciality Hospital Pvt.Ltd.
Nagpur, Maharashtra 440010
0 studies enrolling now · 9 studies all time
What they study most
Colitis, Ulcerative, Crohn's Disease, Hepatorenal Syndrome, Ulcerative Colitis
Studies at this site
- An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
- ABTECT - Maintenance — Running, not enrolling
- A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease — Stopped early
- A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
- A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed
- A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) — Stopped early
- Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis — Completed
- Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients — Completed